FDA makes Alzheimer's drug Leqembi more widely available for use
Published
ViewThe U.S. Food and Drug Administration said it converted its approval of the Alzheimer's drug Leqembi to a traditional approval, allowing the medication to be more widely used.
The FDA added a black-box warning informing patients and health care providers of its safety risks.
Medicare said it would cover a...